A
Aralex
Aachen research explorer
Sign in
Menu
Papers
Authors
Topics
Journals
Patents
Institutions
Departments
Sign in
Papers
Authors
Topics
Journals
Patents
Organizations
Institutions
Departments
Unit
Universitätsklinikum Aachen
6Universitätsklinikum
▲
Sign in to save
2 authors · 2 authorships ·
All papers →
People
2
Search
Sort
Most cited
h-index
Aachen papers
Name
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
▲
Elmar Stickeler
Universitätsklinikum Aachen
·
RWTH Aachen University
Biochemistry, Genetics and Molecular Biology
12.2k
citations
55
h-index
271
Aachen papers
▲
Jens Panse
Universitätsklinikum Aachen
·
RWTH Aachen University
Immunology and Microbiology
10.3k
citations
44
h-index
212
Aachen papers
2 results
Papers
2
Search
Sort
Most cited
Newest
Oldest
Patent citations
Title
Any type
article
review
book-chapter
conference-paper
preprint
dissertation
book
dataset
other
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
Open access
Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study
2024
Blood
conference-abstract
Immunology and Microbiology
Complement system in diseases
4
citations
Abstract P4-04-08: Histological and epigenetic analyses of placenta tissue from breast cancer patients and healthy participants
2020
Cancer Research
conference-abstract
Medicine
Pregnancy and preeclampsia studies
0
citations
2 results